A 23-year-old left NYU to build a blockchain. Mark Cuban backed it. Wall Street just gave it a regulated futures license. And almost nobody outside crypto has heard of Injective.
Injective's mission, as stated by founder Eric Chen, is simple — to create a truly free and fair financial system through decentralization. The blockchain is now backed by Cuban and has grown into a $1.3 billion ecosystem. (Paul Hastings LLP)
In April 2026, Injective futures went live on Bitnomial — a CFTC-approved US regulated exchange — marking the first time Injective entered the officially regulated US derivatives infrastructure. (Paul Hastings LLP)
Merkle Capital in Thailand launched M-INJ — Asia's first regulated investment fund exclusively focused on Injective — supervised directly by Thailand's Securities and Exchange Commission. (mexc)
Injective's governance passed proposal IIP-617 with 99.9% approval — permanently doubling its deflation rate by combining reduced token issuance with a burn mechanism. Every month the protocol uses on-chain revenue to buy INJ from the open market and permanently destroy it. The June 2026 community buyback alone was worth over $315,000. (mexc)
Injective also added a native EVM to its core blockchain — making it a dual-execution environment where Ethereum-based applications can run directly on-chain alongside its existing Cosmos-native apps. (mexc)
Zero gas fees. Cross-chain trading. Deflationary tokenomics. US regulated. Asia regulated.
Built by a college dropout. Backed by a billionaire.
Did you know about Injective before reading this post?